Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay)

Application

Inflammation plays a crucial role in the development and instability of atherosclerotic plaques, a process known as atherogenesis. As a result, inflammatory markers have been evaluated for their association with atherosclerotic vascular disease and their potential to improve cardiovascular disease (CVD) risk stratification.

One such marker is lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme that has been shown to increase the risk of CVD events and stroke by approximately twofold. Lp-PLA2 may represent an important target for lipid-lowering therapy, as reducing its levels could potentially diminish the inflammatory nature of atherosclerosis and plaque vulnerability.

However, it remains unknown whether directly lowering inflammatory markers such as Lp-PLA2 will have a direct, beneficial impact on CVD events and mortality. Further research is needed to determine the clinical significance of targeting inflammatory pathways in the management of cardiovascular disease.

Product Specification

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

Clinical significance

1. Cardiovascular Risk Assessment

2. Identification of Vulnerable Plaques

3. Inflammatory Assessment in Coronary Artery Disease

4. Risk Stratification in Stroke

5. Monitoring Anti-Inflammatory Therapies